Overview

Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes

Status:
No longer available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The Requesting Physician/Investigator contacts Lilly when, based on their medical opinion, a patient meets the criteria for inclusion in the expanded access program.
Details
Lead Sponsor:
Eli Lilly and Company